KK
OLMA icon

KLP Kapitalforvaltning’s Olema Pharmaceuticals OLMA Stock Holding History

KLP Kapitalforvaltning’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Buy
11,900
+3,600
+43% +$48.2K ﹤0.01% 2002
2026
Q1 		$124K Buy
+8,300
New +$185K ﹤0.01% 1993
2025
Q1 		– Sell
-5,100
Closed -$29.7K – 2284
2024
Q4 		$29.7K Buy
+5,100
New +$50.9K ﹤0.01% 2278

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

KLP Kapitalforvaltning's OLMA Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Olema Pharmaceuticals (OLMA) stake by 43% in Q2 2026, buying an estimated $48.2K and bringing the position to 11,900 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

KLP Kapitalforvaltning first reported a position in OLMA in Q4 2024 and has held it in 3 quarters since. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • KLP Kapitalforvaltning held 11,900 shares of Olema Pharmaceuticals worth $149K as of Q2 2026.
  • KLP Kapitalforvaltning bought 3,600 Olema Pharmaceuticals shares in Q2 2026, an estimated $48.2K.
  • Olema Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2002 holding.
  • KLP Kapitalforvaltning first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.